X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · IEX Real-Time Price · USD
1.230
-0.130 (-9.56%)
At close: Apr 23, 2024, 4:00 PM
1.270
+0.040 (3.25%)
After-hours: Apr 23, 2024, 5:09 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $206.56 million as of April 23, 2024. Its market cap has increased by 47.02% in one year.
Market Cap
206.56M
Enterprise Value
150.63M
1-Year Change
47.02%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since November 16, 2017, X4 Pharmaceuticals's market cap has increased from $192.10M to $206.56M, an increase of 7.53%. That is a compound annual growth rate of 1.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 228.40M | 7.94% |
Apr 19, 2024 | 211.60M | 5.01% |
Apr 18, 2024 | 201.50M | 0.40% |
Apr 17, 2024 | 200.70M | -9.47% |
Apr 16, 2024 | 221.70M | 5.62% |
Apr 15, 2024 | 209.90M | -6.71% |
Apr 12, 2024 | 225.00M | 8.49% |
Apr 11, 2024 | 207.40M | 1.22% |
Apr 10, 2024 | 204.90M | -3.94% |
Apr 9, 2024 | 213.30M | -1.52% |
Apr 8, 2024 | 216.60M | -5.87% |
Apr 5, 2024 | 230.10M | -6.80% |
Apr 4, 2024 | 246.90M | - |
Apr 3, 2024 | 246.90M | 6.51% |
Apr 2, 2024 | 231.80M | -2.11% |
Apr 1, 2024 | 236.80M | 1.46% |
Mar 28, 2024 | 233.40M | -1.44% |
Mar 27, 2024 | 236.80M | -2.75% |
Mar 26, 2024 | 243.50M | -0.69% |
Mar 25, 2024 | 245.20M | - |
Mar 22, 2024 | 245.20M | 11.45% |
Mar 21, 2024 | 220.00M | 28.96% |
Mar 20, 2024 | 170.60M | 5.05% |
Mar 19, 2024 | 162.40M | 5.18% |
Mar 18, 2024 | 154.40M | -0.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lineage Cell Therapeutics | 216.81M |
G1 Therapeutics | 214.54M |
Merrimack Pharmaceuticals | 213.91M |
Accuray | 212.22M |
Senseonics Holdings | 211.84M |
Adlai Nortye | 210.68M |
Galectin Therapeutics | 208.62M |
Design Therapeutics | 207.21M |